Successful treatment of pulmonary mucormycosis in a renal transplant recipient with limited pulmonary reserve by combined medical and surgical therapy.

Mucormycosis is a rare opportunistic fungal infection in renal transplant recipients which is associated with exceedingly high mortality when inadequately treated. Risk factors for this infection include diabetes, neutropaenia and immunosuppression. We report a case of pulmonary mucormycosis in a renal allograft recipient with type 2 diabetes and limited pulmonary reserve. The patient was successfully treated with lobectomy and liposomal amphotericin B with preservation of pulmonary and allograft functions. Early recognition of this infection is warranted before dissemination, which carries a poor prognosis.
AuthorsJordan Y Z Li, Tuck Y Yong, Craig A Jurisevic, Graeme R Russ, David I Grove, P Toby H Coates, Alex P S Disney
JournalHeart, lung & circulation (Heart Lung Circ) Vol. 18 Issue 3 Pg. 226-8 (Jun 2009) ISSN: 1444-2892 [Electronic] Australia
PMID18296117 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Antifungal Agents (therapeutic use)
  • Female
  • Humans
  • Immunocompromised Host
  • Kidney Transplantation (immunology)
  • Lung Diseases, Fungal (drug therapy, immunology, surgery)
  • Middle Aged
  • Mucormycosis (drug therapy, immunology, surgery)
  • Pneumonectomy
  • Recovery of Function

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: